Spots Global Cancer Trial Database for Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
Official Title: Evaluation of Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding in Subjects With Secondary Amenorrhea
Study ID: NCT00160199
Conditions
Study Description
Brief Summary: To evaluate the efficacy and safety of 300 mg and 400 mg doses of PROMETRIUM® capsules in women of reproductive age with secondary amenorrhea
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Site 29, Mobile, Alabama, United States
Site 41, Montgomery, Alabama, United States
Site 26, Tucson, Arizona, United States
Site 5, Jonesboro, Arkansas, United States
Site 39, Carmichael, California, United States
Site 17, Encinitas, California, United States
Site 10, San Diego, California, United States
Site 42, Avon, Connecticut, United States
Site 3, Groton, Connecticut, United States
Site 22, New Britian, Connecticut, United States
Site 9, Waterbury, Connecticut, United States
Site 37, West Hartford, Connecticut, United States
Site 14, Aventura, Florida, United States
Site 40, Clearwater, Florida, United States
Site 1, West Palm Beach, Florida, United States
Site 30, West Palm Beach, Florida, United States
Site 46, Atlanta, Georgia, United States
Site 43, Powder Springs, Georgia, United States
Site 36, Champaign, Illinois, United States
Site 12, Chicago, Illinois, United States
Site 6, Baton Rouge, Louisiana, United States
Site 7, Baltimore, Maryland, United States
Site 2, St. Louis, Missouri, United States
Site 16, Reno, Nevada, United States
Site 45, New York, New York, United States
Site 23, New Bern, North Carolina, United States
Site 15, Winston-Salem, North Carolina, United States
Site 28, Winston-Salem, North Carolina, United States
Site 33, Cincinnati, Ohio, United States
Site 32, Erie, Pennsylvania, United States
Site 47, Hershey, Pennsylvania, United States
Site 44, Philadelphia, Pennsylvania, United States
Site 38, Pottstown, Pennsylvania, United States
Site 13, Greenville, South Carolina, United States
Site 8, Conroe, Texas, United States
Site 11, Corpus Christi, Texas, United States
Site 27, Houston, Texas, United States
Site 34, Houston, Texas, United States
Site 24, San Antonio, Texas, United States
Site 35, Salt Lake City, Utah, United States
Site 19, Norfolk, Virginia, United States
Site 4, Seattle, Washington, United States
Contact Details
Name: Global Clinical Director Solvay
Affiliation: Solvay Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
